Pfizer Inc (PFE)

Inventory turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cost of revenue (ttm) US$ in thousands 43,644,000 43,757,000 40,697,000 45,989,000 52,421,000 50,999,000 53,797,000 51,334,000 45,545,000 33,762,000 27,919,000 23,792,000 22,352,000 27,436,000 27,105,000 27,482,000 28,160,000 29,002,000 29,036,000 29,563,000
Inventory US$ in thousands 10,189,000 10,204,000 10,310,000 9,541,000 8,981,000 9,513,000 10,454,000 9,979,000 9,059,000 8,640,000 8,948,000 8,493,000 8,020,000 9,295,000 8,564,000 8,423,000 7,068,000 8,222,000 8,233,000 8,029,000
Inventory turnover 4.28 4.29 3.95 4.82 5.84 5.36 5.15 5.14 5.03 3.91 3.12 2.80 2.79 2.95 3.16 3.26 3.98 3.53 3.53 3.68

December 31, 2023 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $43,644,000K ÷ $10,189,000K
= 4.28

Pfizer Inc.'s inventory turnover has shown some fluctuations in recent quarters. In Q4 2023, the inventory turnover ratio decreased to 2.45 from 2.65 in the previous quarter (Q3 2023), indicating that the company took longer to sell its inventory compared to the prior period. This may suggest potential issues with inventory management or slower sales during the quarter.

Comparing Q4 2023 to the same period in the previous year (Q4 2022), there has been a significant decline in inventory turnover, from 3.82 to 2.45. This suggests a notable increase in the time it takes for Pfizer to sell its inventory, which could be a cause for concern about excess or obsolete inventory levels.

Overall, Pfizer's inventory turnover has been declining over the past quarters, indicating a potential inefficiency in managing and selling inventory. Further analysis and investigation into the company's inventory management practices and sales performance are recommended to address any underlying issues and improve efficiency in this area.


Peer comparison

Dec 31, 2023

Dec 31, 2023


See also:

Pfizer Inc Inventory Turnover (Quarterly Data)